Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies

被引:23
作者
Hernandez, Carlos [1 ]
Arasanz, Hugo [1 ,2 ]
Chocarro, Luisa [1 ]
Bocanegra, Ana [1 ]
Zuazo, Miren [1 ]
Fernandez-Hinojal, Gonzalo [2 ]
Blanco, Ester [1 ]
Vera, Ruth [2 ]
Escors, David [1 ]
Kochan, Grazyna [1 ]
机构
[1] IdISNA, UPNA, Biomed Res Ctr Navarrabiomed, Oncoimmunol Grp, Irunlarrea 3, Pamplona 31008, Spain
[2] IdISNA, Complejo Hosp Navarra, Dept Oncol, Irunlarrea 3, Pamplona 31008, Spain
关键词
immunotherapy; immune checkpoint inhibitors; systemic blood subsets; CD4(+); CD8(+); MDSCs; MISMATCH REPAIR DEFICIENCY; MEMORY T-CELLS; PERIPHERAL-BLOOD; PD-1; BLOCKADE; CLINICAL-SIGNIFICANCE; IPILIMUMAB TREATMENT; PREDICTS RESPONSE; HYPERPROGRESSION; LYMPHOCYTES; INCREASES;
D O I
10.3390/ijms21072411
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of cancer immunotherapy in the last decade has followed a vertiginous rhythm. Nowadays, immune checkpoint inhibitors (ICI) which include anti-CTLA4, anti-PD-1 and anti-PD-L1 antibodies are in clinical use for the treatment of numerous cancers. However, approximately only a third of the patients benefit from ICI therapies. Many efforts have been made for the identification of biomarkers allowing patient stratification into potential responders and progressors before the start of ICI therapies or for monitoring responses during treatment. While much attention is centered on biomarkers from the tumor microenvironment, in many cases biopsies are not available. The identification of systemic immune cell subsets that correlate with responses could provide promising biomarkers. Some of them have been reported to influence the response to ICI therapies, such as proliferation and activation status of CD8 and CD4 T cells, the expression of immune checkpoints in peripheral blood cells and the relative numbers of immunosuppressive cells such as regulatory T cells and myeloid-derived suppressor cells. In addition, the profile of soluble factors in plasma samples could be associated to response or tumor progression. Here we will review the cellular subsets associated to response or progression in different studies and discuss their accuracy in diagnosis.
引用
收藏
页数:13
相关论文
共 63 条
  • [1] Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics
    Arasanz, Hugo
    Zuazo, Miren
    Bocanegra, Ana
    Gato, Maria
    Martinez-Aguillo, Maite
    Morilla, Idoia
    Fernandez, Gonzalo
    Hernandez, Berta
    Lopez, Paul
    Alberdi, Nerea
    Hernandez, Carlos
    Chocarro, Luisa
    Teijeira, Lucia
    Vera, Ruth
    Kochan, Grazyna
    Escors, David
    [J]. CANCERS, 2020, 12 (02)
  • [2] Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
    Bagley, Stephen J.
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua M.
    Alley, Evan W.
    Evans, Tracey L.
    Kosteva, John A.
    Ciunci, Christine A.
    Gabriel, Peter E.
    Thompson, Jeffrey C.
    Stonehouse-Lee, Susan
    Sherry, Victoria E.
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    DiLullo, Gloria
    Cohen, Roger B.
    Vachani, Anil
    Langer, Corey J.
    [J]. LUNG CANCER, 2017, 106 : 1 - 7
  • [3] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
    Bocanegra, Ana
    Fernandez-Hinojal, Gonzalo
    Zuazo-Ibarra, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Hernandez, Carlos
    Ibanez, Maria
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Teijeira, Lucia
    Morilla, Idoia
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [4] Biomarkers for Clinical Benefit of immune Checkpoint inhibitor Treatment-A Review From the Melanoma Perspective and Beyond
    Buder-Bakhaya, Kristina
    Hassel, Jessica C.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] Hyperprogressive disease: recognizing a novel pattern to improve patient management
    Champiat, Stephane
    Ferrara, Roberto
    Massard, Christophe
    Besse, Benjamin
    Marabelle, Aurelien
    Soria, Jean-Charles
    Ferte, Charles
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) : 748 - 762
  • [6] Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
    Champiat, Stephane
    Dercle, Laurent
    Ammari, Samy
    Massard, Christophe
    Hollebecque, Antoine
    Postel-Vinay, Sophie
    Chaput, Nathalie
    Eggermont, Alexander
    Marabelle, Aurelien
    Soria, Jean-Charles
    Ferte, Charles
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (08) : 1920 - 1928
  • [7] Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
    de Coana, Yago Pico
    Wolodarski, Maria
    Poschke, Isabel
    Yoshimoto, Yuya
    Yang, Yuan
    Nystrom, Maria
    Edback, Ulrika
    Brage, Suzanne Eghyazi
    Lundqvist, Andreas
    Masucci, Giuseppe V.
    Hansson, Johan
    Kiessling, Rolf
    [J]. ONCOTARGET, 2017, 8 (13) : 21539 - 21553
  • [8] Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
    Fairfax, Benjamin P.
    Taylor, Chelsea A.
    Watson, Robert A.
    Nassiri, Isar
    Danielli, Sara
    Fang, Hai
    Mahe, Elise A.
    Cooper, Rosalin
    Woodcock, Victoria
    Traill, Zoe
    Al-Mossawi, M. Hussein
    Knight, Julian C.
    Klenerman, Paul
    Payne, Miranda
    Middleton, Mark R.
    [J]. NATURE MEDICINE, 2020, 26 (02) : 193 - +
  • [9] Fujisawa Y, 2018, BRIT J DERMATOL, V179, P224, DOI 10.1111/bjd.16689
  • [10] PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
    Gato-Canas, Maria
    Zuazo, Miren
    Arasanz, Hugo
    Ibanez-Vea, Maria
    Lorenzo, Laura
    Fernandez-Hinojal, Gonzalo
    Vera, Ruth
    Smerdou, Cristian
    Martisova, Eva
    Arozarena, Imanol
    Wellbrock, Claudia
    Llopiz, Diana
    Ruiz, Marta
    Sarobe, Pablo
    Breckpot, Karine
    Kochan, Grazyna
    Escors, David
    [J]. CELL REPORTS, 2017, 20 (08): : 1818 - 1829